Companion Diagnostics Market is Growing Dynamically at a Healthy CAGR of 15.4% During Forecast 2018-2023


Posted January 30, 2020 by gadewarshri2019

companion diagnostics market to exhibit a robust 15.4% CAGR over the 2017 to 2023 forecast period to reach a valuation of more than USD 12 billion

 
Market Overview:
Market Research Future (MRFR) expects the global companion diagnostics market to exhibit a robust 15.4% CAGR over the 2017 to 2023 forecast period to reach a valuation of more than USD 12 billion, according to the latest research report from the market research expert. The report provides a comprehensive overview of the global companion diagnostics market to readers looking to assess the growth prospects of the market and figure out which strategies are likely to work in the market in the coming years. Major drivers and restraints affecting the global companion diagnostics market are profiled in the report to help readers understand the major factors motivating the market in the coming years. Key competitive insights into the companion diagnostics market’s workings are also provided in the report on the back of a detailed analysis of the historical performance of companies in the global market.
The field of companion diagnostics has boomed since the genetics revolution, as more in-depth information about a patient’s tendency to react to certain chemicals has been made available by genetic studies. Increasing availability of detailed information about a patient’s genetic makeup has allowed for the development of effective tests to cross-check various therapeutic products against the genetic tendencies exhibited by the patient. This has led to steady growth of the Companion Diagnostics Market over the last few years.
The increasing demand for personalized medicine in the coming years is likely to be a major driver for the companion diagnostics market. As the genetics field has grown, physicians and medical researchers have been quick to make use of it to develop ways of treating diseases with highly personalized, customized treatment formulations that best suit the individual patient in question.
Competitive Analysis:
• Thermo Fisher Scientific Inc
• Qiagen NV
• Myriad Genetics Inc
• F. Hoffman-La Roche AG
• ARUP Laboratories
• Agilent Technologies
• Abbott Laboratories
Segmentation:
• The global companion diagnostics market is segmented on the basis of technology, application, end use, and region.
• By technology, the global companion diagnostics market is segmented into polymerase chain reaction (PCR), in-situ hybridization, and immunohistochemistry. Of these, the PCR segment holds a dominant 53% share in the global companion diagnostics market and is likely to remain the leading revenue generator over the forecast period.
• By application, the global companion diagnostics market is segmented into cancer, infectious diseases, cardiovascular diseases, central nervous system disorders, and others.
• By end use, the market is segmented into pharma and biotech companies, clinical laboratories, contract research organizations, and others.
Regional Analysis:
The Americas is likely to remain the major revenue generator in the global companion diagnostics market over the forecast period, followed by Europe and Asia Pacific. North America is likely to remain the leading regional market due to the growing presence of the healthcare sector and the strong presence of research avenues into genetics. Asia Pacific is likely to exhibit the highest growth rate.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By gadewar shri
Phone 08329909276
Business Address Office No. 528, Amanora Chambers
Pune - 411028
Country India
Categories Biotech , Business , Health
Tags Companion Diagnostics Market , Companion Diagnostics Market Size , Companion Diagnostics Market Share
Last Updated January 30, 2020